The US Food and Drug Administration (FDA) has granted marketing approval for Hospira, Inc.'s bivalirudin for injection, a generic version of The Medicines Company's Angiomax.
Pharma Major Lupin Limited (Lupin) has entered into a strategic asset purchase agreement with TEMMLER PHARMA GMBH & CO. KG (Temmler), a part of the Aenova Group, one of the world’s largest pharmaceutical contract manufacturers, to acquire Temmler's specialty product portfolio subject to certain closing conditions.

